PW Medtech Group (1358.HK) Earnings Analysis
PW Medtech Group (1358.HK) has no confirmed upcoming earnings date. Trailing P/E 14.56.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1358.HK next report earnings?
No confirmed upcoming earnings date is currently scheduled for 1358.HK. This page updates as the calendar is published.
1358.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-08-30 | 0.04817 HKD | n/a | n/a | n/a |
1358.HK valuation and analyst view
| Trailing P/E | 14.56 |
|---|---|
| Trailing EPS | 0.06148 HKD |
| Price / book | 0.36 |
| Dividend yield | 6.04% |
| Market cap | 1.52B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is PW Medtech Group (1358.HK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 1358.HK. This page updates as the calendar is published.
Did 1358.HK beat earnings last quarter?
Consensus estimate data was not available for 1358.HK's 2024-08-30 report.
What is 1358.HK's current P/E ratio and EPS?
1358.HK trades at a trailing P/E of 14.56 on trailing EPS of 0.06147696910503202 HKD.
What do analysts rate 1358.HK?
1358.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.